![Antony Mattessich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antony Mattessich
Direktor/Vorstandsmitglied bei
AURA BIOSCIENCES, INC.
Vermögen: 175 545 $ am 31.05.2026
Profil
Antony Mattessich is currently an Independent Non-Executive Director at Aura Biosciences, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Amphista Therapeutics Ltd. from 2024 to 2026, President, Chief Executive Officer & Director at Ocular Therapeutix, Inc. from 2017 to 2024, President, Chief Executive Officer & Director at Mundipharma International Ltd. in 2017, Managing Director & Director at Napp Pharmaceutical Holdings Ltd. from 2005 to 2011, Head-Therapeutic Franchise at Novartis AG from 2003 to 2005, and Head of Operations-International Medicines at Bristol Myers Squibb Co. Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,04 % | 17.06.2025 | 23.500 ( 0,04 % ) | 175 545 $ | 31.05.2026 |
Aktive Positionen von Antony Mattessich
| Unternehmen | Position | Beginn |
|---|---|---|
| AURA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 29.09.2021 |
Ehemalige bekannte Positionen von Antony Mattessich
| Unternehmen | Position | Ende |
|---|---|---|
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Vorstandsvorsitzender | 18.03.2026 |
| OCULAR THERAPEUTIX, INC. | Vorstandsvorsitzender | 15.04.2024 |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Vorstandsvorsitzender | 18.12.2017 |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops and provides medicines to patients | Vorstandsvorsitzender | 01.05.2011 |
| NOVARTIS AG | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Antony Mattessich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops and provides medicines to patients | Health Technology |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
